Early MS Treatment Lowers Relapse Rates by 62%

People newly diagnosed with multiple sclerosis who started B-cell therapy early had 62% fewer relapses than those on standard oral treatments.

This breakthrough study gives doctors and patients clearer guidance on which treatments work best right from the start.